GW & Wade’s Precision BioSciences DTIL Stock Holding History

GW & Wade’s Portfolio DTIL Stock Details DTIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-470	Closed	-$5K	–	425
2023 Q3	$5K	Hold	470	–	–	﹤0.01%	401
2023 Q2	$7K	Buy	+470	New	+$10.7K	﹤0.01%	383

Other funds holding DTIL

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

MSAM

Moloney Securities Asset Management Manchester, Missouri $840M AUM 18.11% 1-Year Est. Return

GW & Wade's DTIL Position: Q4 2023 in Review

GW & Wade sold out of Precision BioSciences (DTIL) in Q4 2023, closing a stake of 470 shares — an estimated $5K sold.

GW & Wade first reported a position in DTIL in Q2 2023 and held it in 2 quarters. The position peaked at $7K in Q2 2023. 65 funds tracked by Wall St. Rank hold DTIL as of Q4 2023.

GW & Wade reported no remaining Precision BioSciences position as of Q4 2023 after selling out during the quarter.
GW & Wade sold 470 Precision BioSciences shares in Q4 2023, an estimated $5K.
GW & Wade first reported a position in Precision BioSciences in Q2 2023 and held it in 2 quarters.
GW & Wade's Precision BioSciences position peaked at $7K in Q2 2023.
65 funds tracked by Wall St. Rank held Precision BioSciences as of Q4 2023.

Based on GW & Wade's 13F filing for Q4 2023, filed 8 Feb 2024.